NUVL logo

Nuvalent (NUVL) Company Overview

Profile

Full Name:

Nuvalent, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

July 29, 2021

Indexes:

Not included

Description:

Nuvalent (NUVL) is a biotechnology company focused on developing targeted therapies for cancer. They create innovative treatments that aim to improve patient outcomes by specifically targeting cancer cells while minimizing effects on healthy cells. Their research emphasizes precision medicine to address various types of cancer effectively.

Events Calendar

Earnings

Next earnings date:

May 9, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Feb 27, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Mar 3, 25 HC Wainwright & Co.
Buy
Jan 17, 25 HC Wainwright & Co.
Buy
Dec 30, 24 HC Wainwright & Co.
Buy
Nov 13, 24 BMO Capital
Outperform
Oct 24, 24 UBS
Neutral
Oct 4, 24 JP Morgan
Overweight
Sep 16, 24 Wedbush
Outperform
Sep 16, 24 Stifel
Buy
Sep 16, 24 Guggenheim
Buy
Sep 16, 24 BMO Capital
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Nuvalent?
  • Does Nuvalent pay dividends?
  • What sector is Nuvalent in?
  • What industry is Nuvalent in?
  • What country is Nuvalent based in?
  • When did Nuvalent go public?
  • Is Nuvalent in the S&P 500?
  • Is Nuvalent in the NASDAQ 100?
  • Is Nuvalent in the Dow Jones?
  • When was Nuvalent's last earnings report?
  • When does Nuvalent report earnings?
  • Should I buy Nuvalent stock now?

What is the ticker symbol for Nuvalent?

The ticker symbol for Nuvalent is NASDAQ:NUVL

Does Nuvalent pay dividends?

No, Nuvalent does not pay dividends

What sector is Nuvalent in?

Nuvalent is in the Healthcare sector

What industry is Nuvalent in?

Nuvalent is in the Biotechnology industry

What country is Nuvalent based in?

Nuvalent is headquartered in United States

When did Nuvalent go public?

Nuvalent's initial public offering (IPO) was on July 29, 2021

Is Nuvalent in the S&P 500?

No, Nuvalent is not included in the S&P 500 index

Is Nuvalent in the NASDAQ 100?

No, Nuvalent is not included in the NASDAQ 100 index

Is Nuvalent in the Dow Jones?

No, Nuvalent is not included in the Dow Jones index

When was Nuvalent's last earnings report?

Nuvalent's most recent earnings report was on Nov 12, 2024

When does Nuvalent report earnings?

The next expected earnings date for Nuvalent is May 9, 2025

Should I buy Nuvalent stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions